Communication
Metal Organic Frameworks as Nitric Oxide Catalysts
Jacqueline L. Harding† and Melissa M. Reynolds*,†,‡
‡
†Department of Chemistry and School of Biomedical Engineering, Colorado State University, Fort Collins, Colorado, 80523
S
* Supporting Information
and MOFs offer the potential to be either NO donors or
ABSTRACT: The use of metal organic frameworks
(MOFs) for the catalytic production of nitric oxide
(NO) is reported. In this account we demonstrate the
use of Cu3(BTC)2 as a catalyst for the generation of NO
from the biologically occurring substrate, S-nitrosocysteine
(CysNO). The MOF catalyst was evaluated as an NO
generator by monitoring the evolution of NO in real time
via chemiluminescence. The addition of 2, 10, and 15-fold
excess CysNO to MOF-CuII sites and cysteine (CysH)
resulted in catalytic turnover of the active sites and nearly
100% theoretical yield of the NO product. Control
experiments without the MOF present did not yield
appreciable NO generation. In separate studies the MOF
was found to be reusable over successive iterations of
CysNO additions without loss of activity. Subsequently,
the MOF catalyst was confirmed to remain structurally
intact by pXRD and ATR-IR following reaction with
CysNO and CysH.
catalysts for the generation of NO directly from bioavailable
sources. Recently, the Morris group has demonstrated that Cu-
based zeolites can be used to catalytically produce NO from
nitrite and to store NO. Thus, MOFs and zeolites offer a single
therapeutic substrate that can be designed as either an NO
donor or an NO generator.
While there are numerous bioavailable sources of NO,
including nitrite (176 nM) and S-nitrosothiols (RSNOs) (10
μM), the most abundant and structurally varied species in the
blood are RSNOs. As such, RSNO decomposition has been the
most heavily investigated. RSNOs have been reported to
decompose via several different mechanisms.7 One well-
established mechanism of RSNO decomposition involves a
copper-mediated pathway with thiol reducing equivalents
resulting in the generation of 1 mol of NO and the
corresponding disulfide.7 MOFs have been previously demon-
strated to catalyze a variety of reactions. Thus, we propose that
MOFs can be utilized as catalysts for long-term NO generation
by selectively permitting the diffusion of RSNO substrates to
the active CuII sites.
The general requirements for a MOF−NO catalyst are that
the material is resistant to degradation under the reaction
conditions and has accessible catalytic sites. To this end, three
MOFs were investigated: Cu3(BTC)2 (BTC:1,3,5-benzenetri-
carboxylate), Cu-triazolate, and Fe(BDC) (BDC-benzenedicar-
boxylate). Of these, only Cu3(BTC)2 met the specified
requirements. Cu3(BTC)2 features unsaturated metal sites
and pore sizes up to 18 Å that allow for the accessibility of
the RSNO species to the metal center.8 In addition, previous
reports have demonstrated that Cu3(BTC)2 remains structur-
ally stable after being utilized as a catalyst for other reactions.9
Thus, this well-studied MOF presents an ideal starting point for
studying the catalytic production of NO via the copper-
mediated decomposition of RSNOs. In this work, we report the
first example of using a MOF to catalyze the decomposition of
RSNOs to generate NO.
itric oxide (NO) has been identified as a crucial biological
N
signaling molecule in the cardiovascular,1−3 nervous, and
immune systems.1,4−6 As a result, NO storage and delivery
vehicles have been extensively developed to target a range of
diseases and to control material−cell interactions.2 Current
approaches for NO storage and delivery have primarily focused
on incorporating NO donor moieties such as diazeniumdiolates
(R-N2O2) and S-nitrosothiols (RSNO) onto both organic3 and
inorganic4 substrates. However, the relatively small NO
reservoir that can be stored on such donor substrates ultimately
limits their potential use.
In order to increase the NO loading capacity and expand the
potential use of NO donor materials to more diverse
biomedical applications, porous inorganic materials such as
metal organic frameworks (MOFs) and zeolites have been
investigated as NO storage materials. MOF materials provide
an NO therapeutic substrate with tunable physical and chemical
properties.5 Recently, the Morris, Rosseinsky, and Cohen
groups have postsynthetically modified MOFs with various NO
donor moieties.6 Their work shows that MOF substrates are7
indeed viable NO donor materials. These NO donor MOF
materials have increased storage capacity over previous NO
donors.
Yet, even the use of a MOF substrate does not eliminate the
capacity and NO-release duration limitations that are inherent
in NO donor materials. Long-term biomedical applications
require a therapeutic substrate that is stable and capable of
producing NO for lengthy and sustained periods of time.
Advantageously, structured inorganic materials such as zeolites
As depicted in Figure 1, RSNOs can interact with the CuII
metal sites of Cu3(BTC)2 to decompose RSNO and
subsequently produce NO. The RSNO decomposition reaction
to generate NO via the Cu3(BTC)2 catalyst is shown in Scheme
1. S-Nitrosocysteine (CysNO) was selected as a model RSNO
species because of its reported bioavailability in the micromolar
range.10 In addition, these RSNOs do not decompose
prematurely with reducing equivalents of cysteine (CysH) to
a significant extent (see Table 1). Both reactions were
monitored by measuring the formation of the product, NO.
Received: November 15, 2011
Published: January 20, 2012
© 2012 American Chemical Society
3330
dx.doi.org/10.1021/ja210771m | J. Am. Chem.Soc. 2012, 134, 3330−3333